00:00 Speaker A

Yahoo Finance’s Brooke DePalma joins me here for a look at Moderna, Caesars Entertainment, and Walmart, and we will start here with Moderna. That stock getting a lift after the US Food and Drug Administration agrees to review the drugmaker’s first flu shot of the season. So this one reading up on it Brooke, so the FDA will review uh Moderna a Moderna flu shot made with MRNA technology. And I guess this reverses actually a previous decision.

00:29 Brooke DePalma

Yeah, on February 10th from what I understand, shares fell around 2% after Moderno published the FDA’s refusal to file letter ultimately pulling that stock back. But despite that year to date Moderna has done well because of other drug…